Axa
BEAT

Axa’s BioTelemetry, Inc. BEAT Stock Holding History

Axa’s Portfolio BEAT Stock Details BEAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-5,100
Closed -$208K – 1378
2019
Q3 		$208K Hold
5,100
– – ﹤0.01% 1248
2019
Q2 		$246K Sell
5,100
-63,100
-93% -$3.32M ﹤0.01% 1201
2019
Q1 		$4.27M Buy
68,200
+3,800
+6% +$261K 0.02% 689
2018
Q4 		$3.85M Buy
+64,400
New +$3.87M 0.02% 675

Other funds holding BEAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Axa's BEAT Position: Q4 2019 in Review

Axa sold out of BioTelemetry, Inc. (BEAT) in Q4 2019, closing a stake of 5,100 shares — an estimated $208K sold.

Axa first reported a position in BEAT in Q4 2018 and held it in 4 quarters. The position peaked at $4.27M in Q1 2019. 219 funds tracked by Wall St. Rank hold BEAT as of Q4 2019.

  • Axa reported no remaining BioTelemetry, Inc. position as of Q4 2019 after selling out during the quarter.
  • Axa sold 5,100 BioTelemetry, Inc. shares in Q4 2019, an estimated $208K.
  • Axa first reported a position in BioTelemetry, Inc. in Q4 2018 and held it in 4 quarters.
  • Axa's BioTelemetry, Inc. position peaked at $4.27M in Q1 2019.
  • 219 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q4 2019.

Based on Axa's 13F filing for Q4 2019, filed 18 Feb 2020.